Related Experiment Video
Updated: Jun 28, 2025

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
Published on: February 10, 2021
EphB1 causes retinal damage through inflammatory pathways in the retina and retinal Müller cells
Li Liu1, Youde Jiang1, Mohamed Al-Shabrawey2,3
1Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI.
Purpose:
To examine whether increased ephrin type-B receptor 1 (EphB1) leads to inflammatory mediators in retinal Müller cells.
Methods:
Diabetic human and mouse retinal samples were examined for EphB1 protein levels. Rat Müller cells (rMC-1) were grown in culture and treated with EphB1 siRNA or ephrin B1-Fc to explore inflammatory mediators in cells grown in high glucose. An EphB1 overexpression adeno-associated virus (AAV) was used to increase EphB1 in Müller cells in vivo. Ischemia/reperfusion (I/R) was performed on mice treated with the EphB1 overexpression AAV to explore the actions of EphB1 on retinal neuronal changes in vivo.
Results:
EphB1 protein levels were increased in diabetic human and mouse retinal samples. Knockdown of EphB1 reduced inflammatory mediator levels in Müller cells grown in high glucose. Ephrin B1-Fc increased inflammatory proteins in rMC-1 cells grown in normal and high glucose. Treatment of mice with I/R caused retinal thinning and loss of cell numbers in the ganglion cell layer. This was increased in mice exposed to I/R and treated with the EphB1 overexpressing AAVs.
Conclusions:
EphB1 is increased in the retinas of diabetic humans and mice and in high glucose-treated Müller cells. This increase leads to inflammatory proteins. EphB1 also enhanced retinal damage in response to I/R. Taken together, inhibition of EphB1 may offer a new therapeutic option for diabetic retinopathy.
Insights
Increased ephrin type-B receptor 1 (EphB1) in diabetic retinas promotes inflammation and damage. Inhibiting EphB1 may be a new treatment for diabetic retinopathy.
Area of Science:
- Ophthalmology
- Cell Biology
- Diabetic Complications
Background:
- Diabetic retinopathy is a leading cause of vision loss.
- Inflammation plays a critical role in diabetic retinopathy pathogenesis.
- The role of ephrin type-B receptor 1 (EphB1) in diabetic retinal inflammation is not fully understood.
Purpose of the Study:
- To investigate the role of EphB1 in diabetic retinal inflammation.
- To determine if elevated EphB1 levels contribute to inflammatory mediator production in Müller cells.
- To assess the impact of EphB1 on retinal damage in response to ischemia/reperfusion (I/R).
Main Methods:
- Analyzed EphB1 protein levels in human and mouse diabetic retinas.
- Utilized cultured rat Müller cells (rMC-1) treated with EphB1 siRNA or ephrin B1-Fc under high glucose conditions.
- Employed adeno-associated virus (AAV) to overexpress EphB1 in Müller cells in vivo.
- Induced I/R in mice treated with EphB1-overexpressing AAV to evaluate retinal neuronal changes.
Main Results:
- EphB1 protein levels were elevated in diabetic retinas and high glucose-treated Müller cells.
- Knockdown of EphB1 decreased inflammatory mediators in Müller cells.
- Ephrin B1-Fc treatment increased inflammatory proteins in Müller cells.
- EphB1 overexpression exacerbated retinal thinning and neuronal cell loss following I/R.
Conclusions:
- Elevated EphB1 in diabetic retinas contributes to inflammation and Müller cell activation.
- EphB1 exacerbates retinal damage in models of I/R injury.
- Targeting EphB1 presents a potential therapeutic strategy for diabetic retinopathy.
More Related Videos
Related Concept Videos
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Photoreceptors and Visual Pathways

